The condition commonly known as PCOS, often misunderstood as solely an ovarian cyst disorder, has been renamed to polyendocrine metabolic ovarian syndrome (PMOS), underscoring its hormonal and metabolic roots and redefining how women’s health concerns are addressed.
- New name highlights hormonal and metabolic factors
- Focus shifts from fertility to overall health
- Calls for coordinated, multi-specialty care
What happened
In May 2026, at the European Congress of Endocrinology, the condition known as polycystic ovary syndrome (PCOS) was officially renamed polyendocrine metabolic ovarian syndrome (PMOS). This change reflects a deeper understanding that the condition is more than just about ovarian cysts. The renaming effort took 14 years of international collaboration involving healthcare experts and patient groups to reach agreement.
Previously, the term PCOS led many to believe the condition was primarily linked to ovarian cysts and fertility challenges. However, many women diagnosed with PCOS do not have cysts and may not have fertility concerns, making the old name confusing and limiting. The new term better captures the disorder’s broad impact on multiple hormone systems as well as metabolism.
Why it feels good
For many women, the former PCOS label caused misunderstandings and stigmatization, especially around fertility expectations. PMOS removes these associations, offering a name that aligns more closely with their lived experiences and symptoms, such as insulin resistance, skin issues, and mental health struggles, beyond reproductive concerns.
Experts emphasize that recognizing PMOS as a complex, lifelong endocrine and metabolic condition encourages better patient care. This new framework helps patients feel validated and more accurately directs healthcare providers to address issues like diabetes risk, cardiovascular health, and hormone regulation, rather than focusing narrowly on reproductive symptoms.
What to enjoy or watch next
With PMOS now established, attention will turn to how healthcare systems adapt to this broader understanding. Patients can expect more comprehensive and coordinated care involving endocrinologists, dietitians, mental health professionals, and gynaecologists working together to manage the varied aspects of the condition.
Future research and awareness campaigns are likely to explore better treatment pathways for PMOS, including interventions focused on metabolic health and well-being. This holistic approach promises improved quality of life for women worldwide, making PMOS a milestone in women’s health advancement.